EXPIRED
Notice Number: NOT-MD-19-001
Key Dates
Release Date: March 13, 2019
Issued by
National Institute on Minority Health and Health Disparities (NIMHD)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Disease Prevention (ODP)
Office of Research on Women’s Health (ORWH)
Sexual & Gender Minority Research Office (SGMRO)
Purpose
This Notice calls for research on the health of sexual and gender minority populations. "Sexual and gender minority" is an umbrella term that encompasses lesbian, gay, bisexual, and transgender populations as well as those whose sexual orientation, gender identity and expressions, or reproductive development varies from traditional, societal, cultural, or physiological norms. This includes individuals with disorders or differences of sex development (DSD), sometimes known as intersex.
Although there has been an increase in SGM-focused health research in recent years, there remains a need for further research on the health of these populations. This Notice encourages research that describes the biological, clinical, behavioral, and social processes that affect the health and development of SGM populations and individuals and their families, and that leads to the development of acceptable and appropriate health interventions and health service delivery methods that will enhance health and development of these populations.
Types of research which are relevant to this Notice include, but are not limited to:
Possible funding opportunity announcements (FOAs) or their re-issues to which SGM-related research may be submitted include but are not limited to Parent FOAs for Research (R), Career Development (K), and Fellowship (F) awards (see "Parent Announcements (for Unsolicited or Investigator Initiated Applications)": https://grants.nih.gov/grants/guide/parent_announcements.htm.
Applicants should carefully note the participating Institutes/Centers on each FOA. Applications must be in the mission of an Institute/Center listed in Components of Participating Organizations on the FOA. Offices listed on this Notice may consider co-funding applications assigned to an Institute/Center that participates on the FOA.
Investigators are strongly encouraged to reach out to the relevant contacts as listed below to identify which FOAs may be most appropriate for their proposed project or application.
Applicants should indicate the Notice number (NOT-MD-19-001) in Field 4.b on the SF 424 application form and refer to NOT-MD-19-001 in the abstract to assist in identifying applications submitted to this Notice.
Areas of programmatic interest to NIMHD include but are not limited to:
NIMHD encourages projects to use approaches that encompass multiple domains (e.g., biological, behavioral, socio-cultural, environmental, physical environment, health system) and multiple levels (e.g., individual, interpersonal, community, societal) to understand and address health disparities in SGM populations (see the NIMHD Research Framework, https://www.nimhd.nih.gov/about/overview/research-framework.html, for examples of health determinants of interest). Animal studies and studies focused on SGM populations outside of the US are not priorities for NIMHD under this Notice.
NCCIH is interested in supporting research on the use of complementary and integrative health approaches, including natural products and mind and body interventions, to manage stress, chronic pain, mild anxiety, or depression among SGM populations. NCCIH is also interested in research studying mind and body approaches to improve adherence to treatment (e.g., Medication Assisted Treatment (MAT) for opioid misuse, Antiretroviral therapy (ART) for HIV) and prevention (e.g., Pre-exposure prophylaxis (PrEP) for HIV) regimens to promote health outcomes. Natural products include botanicals, pre/probiotics, and products marketed as dietary supplements. Mind and body approaches include various meditation approaches (e.g., mindfulness), hypnosis or guided imagery, meditative movement approaches (e.g., yoga, tai chi, qi-gong), body-based approaches (e.g., spinal manipulation, massage, mobilization, acupuncture), a combination of these approaches (e.g., meditation and yoga, such as in mindfulness-based stress reduction MBSR), or complex interventions including music and art therapy. NCCIH offers a range of funding opportunity announcements to support clinical trials of natural products and mind and body interventions. Applicants are strongly encouraged to consult with the NCCIH Scientific Research contact prior to developing and submitting an application.
Areas of programmatic interest to NCI include (but are not limited to) studies that:
Areas of programmatic interest to NHGRI include but are not limited to:
NHLBI provides global leadership for a research, research training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI encourages research designed to answer the breadth of scientific questions related to heart, lung, blood, and/or sleep diseases, disorders, and phenotypes. The NHLBI seeks research applications (R01 applications only) that will address questions relevant to the NHLBI mission, address gaps in the NHLBI’s portfolio of clinical and epidemiology cohort studies and should align with the NHLBI’s Strategic Vision. NHLBI’s strategic priorities emphasize the continuum of research from basic molecular biology research to implementation science related to heart, lung, blood, and sleep disorders (e.g., Sickle Cell Disease and other hemoglobinopathies; cardiovascular diseases; hypertension prevention and control; asthma; chronic obstructive pulmonary disease (COPD); sleep apnea; and other cardiopulmonary diseases and conditions), self-management of symptoms and disease conditions, and prevention of these diseases and disorders in various populations. The NHLBI also has significant interests in implementation science research for the prevention, control, and treatment of heart, lung, blood diseases, and sleep disorders, particularly research that addresses the development of interventions or strategies that address the translation of proven-effective, evidence-based interventions into clinical, community, and/or other settings; addresses impediments to uptake, scale up, and sustainability of evidence-based research. Please refer to the NHLBI website for more details on the research priorities of the NHLBI: https://www.nhlbi.nih.gov/about/documents/strategic-vision.
NIA is interested in research that can improve the understanding of aging processes and experiences that impact health and well-being in middle-aged and older SGM adults as well as studies focused on early life exposures that contribute to SGM health disparities in adulthood. NIA encourages use of multi-level analysis of individual, dyadic, family, community/institution, and population data, and consideration of multidimensional measures of sexual orientation (identity, attraction, and behavior) and diverse gender categories. NIA supports cross-national studies to better understand the aging experience on a global level and the effects of various policies. Natural experiments , arising from policy change or regional differences, may provide another powerful approach for examining mechanisms affecting the health of SGM older adults. Applicants are encouraged to leverage NIA’s investment in data infrastructure and publicly available datasets. (See NIA’s Office of Research Resources.)
Areas of programmatic interest to NIA include but are not limited to:
NIAAA seeks innovative applications in the areas of:
Areas of programmatic interest to NIAID include but are not limited to:
The mission of NIAMS is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS also conducts and supports basic research on the normal structure and function of bones, joints, muscles, and skin. Basic research involves a wide variety of scientific disciplines, including immunology, genetics, molecular biology, structural biology, biochemistry, physiology, virology, and pharmacology. Clinical research areas include rheumatology, orthopaedics, dermatology, metabolic bone diseases, heritable disorders of bone and cartilage, inherited and inflammatory muscle diseases, and sports and rehabilitation medicine. NIAMS also seeks studies that include sufficient numbers of SGM individuals to enable robust sub-group analyses. Clinical trials designed to answer specific questions about the safety, tolerability, efficacy, effectiveness, clinical management, and/or implementation of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions will only be supported by NIAMS if submitted to a NIAMS clinical trials-specific FOA. A current list of active NIAMS clinical trials FOAs is available at https://www.niams.nih.gov/grants-funding/conducting-clinical-research/grants. For information regarding NIAMS supported scientific areas/programs and contacts, please see:https://www.niams.nih.gov/grants-funding/supported-scientific-areas.
The NICHD supports biological, behavioral, and clinical research related to conception and pregnancy, normal and abnormal development in childhood, reproductive health, population dynamics across the lifespan, and rehabilitation medicine (https://www.nichd.nih.gov/grantsfunding/opportunities-mechanisms/areas-research/Pages/default.aspx). Research projects considered by funding by NICHD must fall within the scientific missions of the twelve Scientific Branches of the NICHD Division of Extramural Research (DER) or the National Center for Medical Rehabilitation Research (NCMRR). Information about those scientific missions and program staff contacts may be found on the web pages for the DER scientific branches at: http://www.nichd.nih.gov/about/org/der/branches/Pages/index.aspx and the NCMRR at: http://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx. Potential applicants are strongly encouraged to read these webpages for any updates in response to recent scientific advances or emerging public health topics. NICHD encourages applications that address its extramural program priorities and will consider how well research projects align with one or more of those priorities when making award decisions. A detailed list of NICHD high priority research areas may be found at https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areasresearch/Pages/priorities.aspx
Areas of programmatic interest to NIDA include but are not limited to:
Areas of programmatic interest to NIDCR include but are not limited to:
NIDDK supports medical research and research training and dissemination of science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.
Areas of programmatic interest to NIEHS include but are not limited to:
Areas of programmatic interest to NIMH include:
NIMH also seeks studies that:
Areas of programmatic interest to NINDS include but are not limited to:
Inquiries
Please direct all inquiries to:
Jennifer Alvidrez, PhD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-9567
Email: [email protected]
Della B. White, PhD
National Center for Complementary & Integrative Health (NCCIH)
Telephone: 301-827-6358
Email: [email protected]
Elizabeth Perruccio, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6178
Email: [email protected]
Christine Gatlin, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2280
Email: [email protected]
Dave Clark, DrPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: 301-402-2486
Melissa S. Gerald, PhD
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: [email protected]
Robert C. Freeman, PhD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-8820
Email: [email protected]
Keith Crawford, R.Ph., Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2816
Email: [email protected]
Heiyoung Park, PhD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-3507
Email: [email protected]
Regina Bures, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-496-9485
Email: [email protected]
Jeffrey Schulden, MD
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1526
Email: [email protected]
Dena Fischer, DDS, MSD, MS
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4876
Email: [email protected]
Tamara Bavendam, MD, MS
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4733
Email: [email protected]
Thaddeus Schug, PhD
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3319
Email: [email protected]
Beshaun Davis, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-827-5098
Email: [email protected]
Richard T. Benson, MD, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Phone: 301-496-9135
E-mail: [email protected]
Kate Winseck, MSW
Office of Disease Prevention (ODP)
Telephone: 301-827-5583
Email: [email protected]
Victoria Cargill, MD, MSCE, AAHIVS
Office of Research on Women’s Health (ORWH)
Telephone: 301-435-0971
Email: [email protected]